Project Grant HT94252310562
- The University of Florida received a $482,708 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Combined Therapeutic Acute Intermittent Hypoxia and Respiratory-Triggered Diaphragm Pacing to Restore Breathing Function in Chronic Cervical Spinal Cord Injury". The research will be conducted in Gainesville, FL from September 30, 2025 through September 29, 2028. The goal of the project is to...
- The U.S. Defense Health Agency awarded a $737,500 Project Grant to Florida International University (FIU) under the Military Medical Research and Development program (CFDA 12.420) to develop a novel treatment for spinal cord injury-neuropathic pain by targeting fibroblast-derived PI16. The award has a performance period from May 15, 2025 to May 14, 2028. FIU, a Hispanic-Serving Institution and one of the largest minority-serving research universities in the U.S., will leverage its diverse...
- The University of Florida was awarded a $304,894 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to develop localized oxygen delivery using silk fibroin-based micro-particles loaded with salmon hemoglobin from March 15, 2021 through March 14, 2023. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
- The University of Florida Division of Sponsored Research was awarded a $745,408 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on April 1, 2024, will support research on the "Contribution of Repeat Associated Non-AUG (RAN) Proteins in Friedreich's and Other Hereditary Ataxias" over a 4-year period through March 31, 2028. This research aims to advance the understanding and...
- The University of Florida (UF) Division of Sponsored Research has been awarded a $2,235,400 Project Grant from the Department of Defense's Military Medical Research and Development program (CFDA 12.420). The award, effective April 1, 2024 through March 31, 2028, will support research on the "Contribution of Repeat Associated Non-AUG (RAN) Proteins in Friedreich's and Other Hereditary Ataxias." This project grant is part of the Military Medical Research and Development program, which...
- This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) in the amount of $1,765,321.00 was awarded to the University of Miami on September 30, 2023. The funding supports a four-year research project to develop functionalized peptide gels and utilize Schwann cells for repairing injured spinal cords. The University of Miami is the prime grantee and may collaborate with other research institutions as sub-grantees to execute...
- The University of Florida was awarded a $305,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from March 2021 through March 2024 to develop novel therapies for dystonia. Through this funding, the University of Florida Division of Sponsored Research will conduct research into medical solutions for dystonia that can potentially transform healthcare for service members and the...
- This Project Grant award of $1,332,764.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is funding the "Therapeutic Development of NC101 for Promoting Neurological Recovery After Chronic SCI" by Neurocreis, Inc. in College Station, TX. The award, which runs from July 1, 2025 to June 30, 2028, supports advanced biomedical research aimed at developing innovative medical solutions to address critical health challenges for military...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $746,972.00 to Texas A&M University to conduct research on "PROTECTING THE INJURED SPINAL CORD: MODULATING AUTONOMIC FUNCTION AFTER SPINAL CORD INJURY (SCI) TO REDUCE TISSUE LOSS AND IMPROVE NEUROLOGICAL OUTCOME". The research seeks to develop new treatments to improve outcomes for individuals with spinal cord injuries by investigating...
- The University of Florida was awarded a $1,166,594 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from September 1, 2025 to August 31, 2029, will fund research to investigate "Early Cardiac Biomarkers of Inflammation and Remodeling in DMD" at the University's location in Gainesville, FL. This research aims to transform healthcare for military service members, veterans, and the...
The University of Florida's Division of Sponsored Research received a $718,988 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The 3-year project aims to test a novel oxygen release therapeutic for the preservation of spinal cord tissue resulting from spinal cord injury ischemia. Key products and services to be delivered include: The award period runs from September 1, 2023 to August 31, 2026.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $719.0k | 6/14/23 |
GrantNumber | Description | Subgrantee | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
SUB00003847S | North Florida Foundation For Research And Education, Inc. | Project Grant HT94252310562 | $107.9k | 9/21/23 |